OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment
Bénédikt Jacobs, Veronika Gebel, Lukas Heger, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Bénédikt Jacobs, Veronika Gebel, Lukas Heger, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Showing 14 citing articles:
Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity
Qingqing Zhang, Qing Zhao, Tao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 943-960.e9
Closed Access | Times Cited: 149
Qingqing Zhang, Qing Zhao, Tao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 943-960.e9
Closed Access | Times Cited: 149
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 140
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 140
EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy
Shanshan Sun, Yu Feng, Danying Xu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188700-188700
Open Access | Times Cited: 48
Shanshan Sun, Yu Feng, Danying Xu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188700-188700
Open Access | Times Cited: 48
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors
Lukas Heger, Lukas Hatscher, Chunguang Liang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 17
Lukas Heger, Lukas Hatscher, Chunguang Liang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 17
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Elisa C. Toffoli, A.A. van Vliet, C.D. Forbes, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 2, pp. 159-171
Open Access | Times Cited: 3
Elisa C. Toffoli, A.A. van Vliet, C.D. Forbes, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 2, pp. 159-171
Open Access | Times Cited: 3
CAR-T Cells Targeting Immune Checkpoint Pathway Players
Vita Golubovskaya
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 13
Vita Golubovskaya
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 13
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors
Alessia Floerchinger, Jessica E. Klein, Maximiliane S. C. Finkbeiner, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Alessia Floerchinger, Jessica E. Klein, Maximiliane S. C. Finkbeiner, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies
Liping Wang, Zhe Chen, Guohong Liu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 990-1004
Open Access | Times Cited: 10
Liping Wang, Zhe Chen, Guohong Liu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 990-1004
Open Access | Times Cited: 10
The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment
Anna V. Gorodilova, Kristina V. Kitaeva, Ivan Y. Filin, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8053-8070
Open Access | Times Cited: 4
Anna V. Gorodilova, Kristina V. Kitaeva, Ivan Y. Filin, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8053-8070
Open Access | Times Cited: 4
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment
Cordelia Dunai, Erik Ames, María C. Ochoa, et al.
International review of cell and molecular biology (2022), pp. 65-122
Closed Access | Times Cited: 5
Cordelia Dunai, Erik Ames, María C. Ochoa, et al.
International review of cell and molecular biology (2022), pp. 65-122
Closed Access | Times Cited: 5
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
Lukas Heger, Gordon F. Heidkamp, Lukas Amon, et al.
OncoImmunology (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Lukas Heger, Gordon F. Heidkamp, Lukas Amon, et al.
OncoImmunology (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells
Ildefonso Sánchez‐Cerrillo, Olga Popova, María Agudo-Lera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ildefonso Sánchez‐Cerrillo, Olga Popova, María Agudo-Lera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
On the TRAIL of a killer: mechanisms of action of an allogeneic NK cell therapy
Amanda Antoinette van Vliet
(2024)
Open Access
Amanda Antoinette van Vliet
(2024)
Open Access
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
Jie Shao, Kai Xin, Zhaoye Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Jie Shao, Kai Xin, Zhaoye Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
